Australia markets open in 5 hours 14 minutes

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.65-0.18 (-0.46%)
As of 02:46PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-484,272
-436,367
-248,705
-187,091
-108,159
-
Depreciation & amortisation
9,539
9,309
9,656
7,332
6,545
-
Stock-based compensation
68,281
61,772
31,196
20,724
8,886
-
Change in working capital
-7,512
36,752
-13,489
8,724
-8,304
-
Accounts receivable
3,995
3,419
1,256
464
2,344
-
Accounts payable
4,559
32,469
7,288
2,239
305
-
Other working capital
-457,879
-358,301
-235,217
-153,708
-102,997
-
Net cash provided by operating activities
-448,741
-350,572
-224,401
-147,180
-100,064
-
Cash flows from investing activities
Investments in property, plant and equipment
-9,138
-7,729
-10,816
-6,528
-2,933
-
Purchases of investments
-1,567,500
-1,058,916
-612,769
-671,335
-544,133
-
Sales/maturities of investments
982,078
724,047
599,469
535,746
312,833
-
Other investing activities
-
-
-
-
-
6,000
Net cash used for investing activities
-594,560
-342,598
-24,116
-142,117
-234,233
-
Cash flows from financing activities
Common stock issued
62,053
385,759
298,045
291,241
420,067
-
Other financing activities
-
836,808
42
-424
-
-1,602
Net cash used provided by (used for) financing activities
905,805
1,229,200
301,432
294,179
422,776
-
Net change in cash
-137,496
536,030
52,915
4,882
88,479
-
Cash at beginning of period
428,959
163,149
110,234
105,352
16,873
-
Cash at end of period
291,463
699,179
163,149
110,234
105,352
-
Free cash flow
Operating cash flow
-448,741
-350,572
-224,401
-147,180
-100,064
-
Capital expenditure
-9,138
-7,729
-10,816
-6,528
-2,933
-
Free cash flow
-457,879
-358,301
-235,217
-153,708
-102,997
-